总时间（秒）：26.22
问答时间（秒）：26.10

Okay, let's process the provided text and generate the JSON output based on the provided requirements.

```json
{
  "Variants Include": [
    {
      "Gene": "UNC13A",
      "variants": [
        {
          "HGVS": "NM_005947.4:c.2565G>A",
          "cDNA Change": {
            "transcript": "NM_005947.4",
            "ref": "G",
            "alt": "A",
            "position": "2565"
          },
          "Protein Change": {
            "ref": "G",
            "alt": "A",
            "position": "855"
          },
          "Description in input context": "c.2565G>A (p.R855Q)"
        },
        {
          "HGVS": "NM_005947.4:c.2858A>T",
          "cDNA Change": {
            "transcript": "NM_005947.4",
            "ref": "A",
            "alt": "T",
            "position": "2858"
          },
          "Protein Change": {
            "ref": "A",
            "alt": "T",
            "position": "953"
          },
          "Description in input context": "c.2858A>T (p.N953S)"
        }
      ]
    }
  ],
  "Described Disease": {
    "Described Disease": "Spastic Paraparesis",
    "MONDO": "MONDO:0007979"
  },
  "Experiment Method": [
    {
      "Assay Method": "Quantitative RT-PCR",
      "Material used": {
        "Material Source": "Cell line",
        "Material Name": "HEK293",
        "Description": "cDNA was synthesized from total RNA extracted from HEK293 cells."
      },
      "Readout type": "Quantitative",
      "Readout description": [
        {
          "Variant": "NM_005947.4:c.2565G>A",
          "Conclusion": "Abnormal",
          "Molecular Effect": "complete loss-of-function",
          "Result Description": "UNC13A transcript levels were significantly reduced for the variant NM_005947.4:c.2565G>A compared to wild-type."
        },
        {
          "Variant": "NM_005947.4:c.2858A>T",
          "Conclusion": "Abnormal",
          "Molecular Effect": "complete loss-of-function",
          "Result Description": "UNC13A transcript levels were significantly reduced for the variant NM_005947.4:c.2858A>T compared to wild-type."
        }
      ],
      "Biological replicates": {
        "Biological replicates": "Yes",
        "Description": "Experiments were repeated three times on different days to account for biological variability."
      },
      "Technical replicates": {
        "Technical replicates": "Yes",
        "Description": "Each sample was run in triplicate."
      },
      "Basic positive control": {
        "Basic positive control": "Yes",
        "Description": "Wild-type cDNA was used as a positive control."
      },
      "Basic negative control": {
        "Basic negative control": "Yes",
        "Description": "Empty vector was used as a negative control."
      },
      "Validation controls P/LP": {
        "Validation controls P/LP": "No",
        "Counts": "0"
      },
      "Validation controls B/LB": {
        "Validation controls B/LB": "No",
        "Counts": "0"
      },
      "Statistical analysis method": {
        "Statistical analysis method": "t-test was used for statistical analysis."
      },
      "Threshold for normal readout": {
        "Threshold for normal readout": "UNC13A expression level greater than 20% of wild-type.",
        "Source": "Literature"
      },
      "Threshold for abnormal readout": {
        "Threshold for abnormal readout": "UNC13A expression level less than 5% of wild-type.",
        "Source": "Literature"
      },
      "Approved assay": {
        "Approved assay": "Yes"
      }
    }
  ]
}
```

**Explanation and Assumptions:**

*   **HGVS Nomenclature:**  I used the text provided to extract the HGVS nomenclature.
*   **MONDO Term:** The MONDO term was derived from the context provided in the prompt, based on the disease "Spastic Paraparesis."
*   **Molecular Effect:**  I inferred "complete loss-of-function" based on the description of significantly reduced transcript levels.
*   **Validation Controls**: Since there was no description of validation controls, I set them to "No" and the "Counts" to "0."
*   **Thresholds:**  I extracted the provided thresholds and indicated they were "Literature" based sources.
*   **Material Source:** Cell Line - HEK293
*   **Assay Method:** Quantitative RT-PCR
*   **Statistical Analysis Method:** "t-test was used for statistical analysis."
*   **Biological and Technical Replicates**: "Experiments were repeated three times on different days to account for biological variability." and "Each sample was run in triplicate."

**Important Considerations:**

*   **Data Completeness:**  The completeness of the output depends entirely on the detail provided in the text.
*   **Inferences:** I made some inferences based on context. These assumptions should be validated.
*   **MonDO Database Access:** To accurately populate the "MONDO" field, you would typically need to query the MonDO database using the disease name.
*   **HGVS Nomenclature API:**  Using an API specifically designed for HGVS nomenclature can improve accuracy and standardization.